Trial NCT00176839

View at ClinicalTrials.gov 
Org. Study IDs: 2000LS040
Secondary IDs: 0005M52481 MT2000-12

Last trial update was posted on 2017-12-05

MeSH Interventions

Antilymphocyte Serum Busulfan Cyclophosphamide Lenograstim Melphalan

MeSH Conditions

Hematologic Neoplasms Leukemia, Lymphoid Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

AML Leukemia, Lymphocytic, Acute MDS

Stopping Reasons

Replaced by a different study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID